An investigation by the Associated Press and the Center for Public Integrity sheds light on the political machinations that helped pave the way for America's opioid addiction crisis.
Pharmaceutical interests spent $880 million on lobbying state and federal lawmakers and regulators over the past decade, the investigation found. In contrast, groups that were pushing for greater restrictions on opioids collectively spent only $4 million.
Like all major business interests, pharma also spent big on political campaigns, delivering contributions to 7,100 candidates for state office during the timeframe examined.
Recommended For You
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
